Lamotrigine initiation with valproate and OCP counselling (MEQ)

(i) Polarity and evidence. Depression-predominant bipolar I maintenance is a core lamotrigine niche. Goodwin pooled analysis of two 18-month RCTs supports delay of mood episodes with relatively greater depression-pole protection versus lithium's relative mania-pole strength. Geddes meta-analysis supports a modest acute bipolar depression effect with slow onset. Do not claim acute antimanic monotherapy efficacy.[1][2]

(ii) Titration with valproate. Valproate inhibits lamotrigine metabolism and raises LTG exposure. Use the valproate co-therapy product table: lower start and slower escalation than the monotherapy 25 mg then 50 mg fortnightly scaffold (classically half-rate teaching). Write exact steps from local PI; educate that rushing titration is a rash risk. Review after each step.[3][8]

(iii) OCP interaction. Combined ethinylestradiol contraceptives reduce lamotrigine levels (induced clearance). She is already on an OCP — expect relatively lower LTG exposure than without OCP; individualise target and consider levels if available. If she later stops the pill, LTG levels rise — plan dose review to avoid toxicity. If she switches OCP brands/doses, reassess. This is not the carbamazepine contraceptive-failure lecture, but comprehensive contraception counselling still belongs in bipolar care.[4][5]

(iv) Rash red flags. Progressive widespread rash, blistering, skin pain, mucosal erosions (mouth/eyes/genitals), fever, facial swelling, lymphadenopathy, organ symptoms. Action: stop lamotrigine same day, urgent assessment, SJS/TEN/DRESS pathway as indicated; no rechallenge after confirmed SJS/TEN.[6]

(v) Pregnancy. If planning conception, discuss comparative AED malformation data (EURAP): lamotrigine is generally more favourable than valproate but not risk-free; valproate hierarchy is harsh for pregnancy potential. Clearance rises in pregnancy (levels may fall) and falls postpartum — coordinate perinatal psychiatry and dose/level planning. Shared decision, folate and obstetric pathways as per local standards.[7]